Detalles de la búsqueda
1.
FOLFIRINOX or gemcitabine/nab-paclitaxel in advanced pancreatic adenocarcinoma: A novel validated prognostic score to facilitate treatment decision-making in real-world.
Int J Cancer
; 152(3): 458-469, 2023 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36053905
2.
Survival after secondary liver resection in metastatic colorectal cancer: Comparing data of three prospective randomized European trials (LICC, CELIM, FIRE-3).
Int J Cancer
; 150(8): 1341-1349, 2022 04 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34807464
3.
Current treatment landscape of pancreatic cancer patients in a network of office-based oncologists in Germany.
Future Oncol
; 2022 Dec 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-36533962
4.
BRAF testing in metastatic colorectal carcinoma and novel, chemotherapy-free therapeutic options.
Pathologe
; 42(Suppl 1): 98-109, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34259881
5.
[BRAF-V600E testing in metastatic colorectal cancer and new, chemotherapy-free therapy options. German version]. / BRAF-V600E-Testung beim metastasierten kolorektalen Karzinom und neue, chemotherapiefreie Therapieoptionen.
Pathologe
; 42(6): 578-590, 2021 Nov.
Artículo
en Alemán
| MEDLINE | ID: mdl-33956173
6.
Phase III randomized, double-blind study of paclitaxel with and without everolimus in patients with advanced gastric or esophagogastric junction carcinoma who have progressed after therapy with a fluoropyrimidine/platinum-containing regimen (RADPAC).
Int J Cancer
; 147(9): 2493-2502, 2020 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32339253
7.
Clinical Practice Observation of Trastuzumab in Patients with Human Epidermal Growth Receptor 2-Positive Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction.
Oncologist
; 25(8): e1181-e1187, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32311799
8.
Serial Circulating Tumor DNA Mutational Status in Patients with KRAS-Mutant Metastatic Colorectal Cancer from the Phase 3 AIO KRK0207 Trial.
Clin Chem
; 66(12): 1510-1520, 2020 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33257977
9.
Ipilimumab or FOLFOX with Nivolumab and Trastuzumab in previously untreated HER2-positive locally advanced or metastatic EsophagoGastric Adenocarcinoma - the randomized phase 2 INTEGA trial (AIO STO 0217).
BMC Cancer
; 20(1): 503, 2020 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32487035
10.
[Prerequisites of magnetic resonance imaging for treatment planning in locally advanced rectal cancer - Interdisciplinary recommendations]. / Stellenwert und qualitative Voraussetzungen der Magnetresonanztomografie für die Therapieplanung beim lokal fortgeschrittenen Rektumkarzinom Interdisziplinäre Empfehlungen.
Z Gastroenterol
; 58(6): 577-582, 2020 Jun.
Artículo
en Alemán
| MEDLINE | ID: mdl-32544967
11.
Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial.
Lancet Oncol
; 20(3): 420-435, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30718072
12.
Results from the prospective German TPK clinical cohort study: Treatment algorithms and survival of 1,174 patients with locally advanced, inoperable, or metastatic pancreatic ductal adenocarcinoma.
Int J Cancer
; 144(5): 981-990, 2019 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30006989
13.
Cytokeratin-18 fragments predict treatment response and overall survival in gastric cancer in a randomized controlled trial.
Tumour Biol
; 40(3): 1010428318764007, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-29534639
14.
Methylated free-circulating HPP1 DNA is an early response marker in patients with metastatic colorectal cancer.
Int J Cancer
; 140(9): 2134-2144, 2017 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28124380
15.
Clinicopathological factors influencing outcome in metastatic colorectal cancer patients treated with fluoropyrimidine and bevacizumab maintenance treatment vs observation: an individual patient data meta-analysis of two phase 3 trials.
Br J Cancer
; 117(12): 1768-1776, 2017 Dec 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29123255
16.
Sunitinib added to FOLFIRI versus FOLFIRI in patients with chemorefractory advanced adenocarcinoma of the stomach or lower esophagus: a randomized, placebo-controlled phase II AIO trial with serum biomarker program.
BMC Cancer
; 16: 699, 2016 08 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-27582078
17.
Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial.
Lancet Oncol
; 16(13): 1355-69, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26361971
18.
Impact of hand-foot skin reaction on treatment outcome in patients receiving capecitabine plus erlotinib for advanced pancreatic cancer: a subgroup analysis from AIO-PK0104.
Acta Oncol
; 54(7): 993-1000, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25924969
19.
Gemcitabine plus erlotinib followed by capecitabine versus capecitabine plus erlotinib followed by gemcitabine in advanced pancreatic cancer: final results of a randomised phase 3 trial of the 'Arbeitsgemeinschaft Internistische Onkologie' (AIO-PK0104).
Gut
; 62(5): 751-9, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22773551
20.
First-Line Nivolumab and Relatlimab Plus Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma: The Phase II RELATIVITY-060 Study.
J Clin Oncol
; 42(17): 2080-2093, 2024 Jun 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38723227